At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Jun 3, 2008 crowley john f Officer Automatic Sell 3,700 10.08 - 10.44
Nov 14, 2008 bloch stephen m Director Automatic Sell 3,800 9.34
Nov 4, 2008 bloch stephen m Director Automatic Sell 3,800 10.54
Aug 1, 2008 crowley john f Officer Automatic Sell 3,800 15.42 - 15.43
Jul 26, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 3,896 11.19 - 11.42
Jul 26, 2007 topper james n Director Buy 3,896 11.19 - 11.42
Nov 5, 2008 bloch stephen m Director Automatic Sell 3,900 10.04
Jul 26, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 4,104 11.44 - 11.50
Jul 26, 2007 topper james n Director Buy 4,104 11.44 - 11.50
Aug 7, 2008 bloch stephen m Director Automatic Sell 4,200 16.58
Aug 26, 2008 bloch stephen m Director Automatic Sell 4,200 13.64
Jun 28, 2007 fhm iv lp Beneficial Owner (10% or more) Buy 4,281 11.48 - 11.50
Jun 28, 2007 topper james n Director Buy 4,281 11.48 - 11.50
Sep 15, 2008 bloch stephen m Director Automatic Sell 4,400 14.07
Mar 3, 2008 crowley john f Officer Automatic Sell 4,497 10.00
Aug 4, 2008 bloch stephen m Director Automatic Sell 4,500 15.23
Mar 4, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 4,500 9.60 - 9.84
Aug 19, 2008 patterson matthew r Officer Automatic Sell 4,500 13.71 - 14.50
Mar 4, 2008 topper james n Director Buy 4,500 9.60 - 9.84
Jul 30, 2008 bloch stephen m Director Automatic Sell 4,700 15.19
Showing 181-200 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy